From Medscape Gastroenterology

Medscape Medical News from:

The International Liver Congress 2012

April 18 - 22, 2012; Barcelona, Spain

This coverage is not sanctioned by, nor a part of, the European Association for the Study
of the Liver.

Conference News

EASL New Drugs Require New Terms for HCV Virologic Response
Medscape Medical News, May 8, 2012
EASL Lab Values Predict Acute-on-Chronic Liver Failure Mortality
Medscape Medical News, May 2, 2012
EASL Two Oral Drugs Clear HCV Without Interferon
Medscape Medical News, May 2, 2012
EASL Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 Weeks
Medscape Medical News, May 2, 2012
EASL New Antivirals Show Poor Safety in HCV With Cirrhosis
Medscape Medical News, May 2, 2012
EASL New HCV Drug Induces Rapid, Durable Drops in Viral Load
Medscape Medical News, April 30, 2012
EASL Interferon Lambda Beats Alfa in Clearing HCV Genotype 2 or 3
Medscape Medical News, April 27, 2012
EASL Nonalcoholic Fatty Liver Disease Raises Liver Cancer Risk
Medscape Medical News, April 25, 2012
EASL New Protease Inhibitor TMC435 Cures Most HCV Patients
Medscape Medical News, April 24, 2012
EASL Pancreatitis Events Halt Development of Alisporivir for HCV
Medscape Medical News, April 19, 2012

Medscape Gastroenterology© WebMD, LLC

Previous Liver Conference Coverage

European Association for the Study of the Liver (EASL) 46th Annual Meeting

European Association for the Study of the Liver (EASL) 45th Annual Meeting

European Association for the Study of the Liver (EASL) 44th Annual Meeting